Repros Therapeutics

Repros Therapeutics is a biopharmaceutical company that specializes in the development of new drugs to treat hormonal and reproductive system disorders. The company was founded in 1987 and is based in The Woodlands, Texas.

History

Repros Therapeutics was established in 1987 with the aim of developing innovative treatments for reproductive disorders. Over the years, the company has expanded its focus to include other hormonal and metabolic disorders.

Products and Research

Repros Therapeutics has developed several notable products. One of its most well-known drugs is Androxal, a treatment for testosterone deficiency in men. The company has also developed Proellex, a drug used to treat symptoms of uterine fibroids and endometriosis.

In addition to these products, Repros Therapeutics is involved in ongoing research and development efforts. The company's research team is currently investigating new treatments for polycystic ovary syndrome (PCOS), hypogonadism, and other hormonal disorders.

Financial Information

Repros Therapeutics is a publicly traded company listed on the NASDAQ stock exchange. The company's financial performance is closely watched by investors and analysts in the biopharmaceutical industry.

Criticism and Controversy

Like many biopharmaceutical companies, Repros Therapeutics has faced criticism and controversy. Some critics have questioned the efficacy and safety of the company's products, while others have raised concerns about the company's business practices.

See Also

• Biopharmaceutical
• Endocrinology
• Reproductive medicine

References

<img src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Searchtool.svg/40px-Searchtool.svg.png" alt="Stub icon" width="40" height="40" />

This biopharmaceutical related article is a stub. You can help WikiMD by expanding it.